D.E. Shaw & Co
APVO icon

D.E. Shaw & Co’s Aptevo Therapeutics APVO Stock Holding History

D.E. Shaw & Co’s Portfolio APVO Stock Details APVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Hold
0
– -$370K – 3580
2018
Q4 		– Hold
0
– – – 3253
2018
Q3 		– Hold
0
– – – 2395
2018
Q2 		– Hold
0
– – – 2398
2018
Q1 		– Hold
0
– – – 2539
2017
Q4 		– Hold
0
– – – 2388
2017
Q3 		– Hold
0
– – – 2625
2017
Q2 		– Hold
0
– – – 2671
2017
Q1 		– Hold
0
– – – 2562
2016
Q4 		– Hold
0
– – – 2596
2016
Q3 		– Hold
0
– – – 2401

Other funds holding APVO

SCM
Stonepine Capital Management Bend, Oregon $114M AUM 77.6% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $57.5B AUM 55.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SC
Sessa Capital New York $5.26B AUM 47.23% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.13B AUM 47.25% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.3B AUM 33.54% 1-Year Est. Return
6CM
683 Capital Management New York $1.08B AUM 85.52% 1-Year Est. Return